Search research articles
Contact Us
Filters
Showing results (291-300 of 340) with videos related to
Page
of 34
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)
|
September 8, 2011
Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917
James R Marshall, Catherine M Tangen, Wael A Sakr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2018
Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial
Terry A Day, Keisuke Shirai, Paul E O'Brien, et al.
Cancer Medicine
|
February 1, 2023
Deep learning-based pathology image analysis predicts cancer progression risk in patients with oral leukoplakia
Xinyi Zhang, Frederico O Gleber-Netto, Shidan Wang, et al.
Cancer Research
|
April 5, 2017
Precancer Atlas to Drive Precision Prevention Trials
Avrum Spira, Matthew B Yurgelun, Ludmil Alexandrov, et al.
The Prostate
|
March 21, 2017
Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial
Danyelle A Winchester, Cathee Till, Phyllis J Goodman, et al.
Nature Reviews. Cancer
|
October 1, 2024
Defining precancer: a grand challenge for the cancer community
Jessica Faupel-Badger, Indu Kohaar, Manisha Bahl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2021
Establishment of Patient-Derived Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response
Mayra Yebra, Shruti Bhargava, Avi Kumar, et al.
Science Translational Medicine
|
February 28, 2024
A functional identification platform reveals frequent, spontaneous neoantigen-specific T cell responses in patients with cancer
Aaron M Miller, Zeynep Koşaloğlu-Yalçın, Luise Westernberg, et al.
The Prostate
|
January 16, 2016
Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial
Danyelle A Winchester, Bora Gurel, Cathee Till, et al.
Communications Medicine
|
May 23, 2022
Early-stage multi-cancer detection using an extracellular vesicle protein-based blood test
Juan Pablo Hinestrosa, Razelle Kurzrock, Jean M Lewis, et al.
Page
of 34
Search research articles
Search
Showing results (291-300 of 340) with videos related to
Sort By:
Page
of 34
Cancer Prevention Research (Philadelphia, Pa.)
|
September 8, 2011
Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917
James R Marshall, Catherine M Tangen, Wael A Sakr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2018
Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial
Terry A Day, Keisuke Shirai, Paul E O'Brien, et al.
Cancer Medicine
|
February 1, 2023
Deep learning-based pathology image analysis predicts cancer progression risk in patients with oral leukoplakia
Xinyi Zhang, Frederico O Gleber-Netto, Shidan Wang, et al.
Cancer Research
|
April 5, 2017
Precancer Atlas to Drive Precision Prevention Trials
Avrum Spira, Matthew B Yurgelun, Ludmil Alexandrov, et al.
The Prostate
|
March 21, 2017
Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial
Danyelle A Winchester, Cathee Till, Phyllis J Goodman, et al.
Nature Reviews. Cancer
|
October 1, 2024
Defining precancer: a grand challenge for the cancer community
Jessica Faupel-Badger, Indu Kohaar, Manisha Bahl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2021
Establishment of Patient-Derived Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response
Mayra Yebra, Shruti Bhargava, Avi Kumar, et al.
Science Translational Medicine
|
February 28, 2024
A functional identification platform reveals frequent, spontaneous neoantigen-specific T cell responses in patients with cancer
Aaron M Miller, Zeynep Koşaloğlu-Yalçın, Luise Westernberg, et al.
The Prostate
|
January 16, 2016
Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial
Danyelle A Winchester, Bora Gurel, Cathee Till, et al.
Communications Medicine
|
May 23, 2022
Early-stage multi-cancer detection using an extracellular vesicle protein-based blood test
Juan Pablo Hinestrosa, Razelle Kurzrock, Jean M Lewis, et al.
Page
of 34